Drug Profile
Epothilone D - Qrono
Alternative Names: Epothilone D Qx; QR 206Latest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator Qrono
- Class Antineoplastics; Epothilones; Small molecules
- Mechanism of Action Mitosis inhibitors; Tubulin polymerisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Cancer
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for clinical-Phase-Unknown development in Cancer in USA (Parenteral, Injection)
- 21 Aug 2017 Epothilone D - Qrono is available for licensing as of 21 Aug 2017. http://qrono.com/pipeline/
- 21 Aug 2017 Clinical trials in Cancer in USA (unspecified route) (Qrono pipeline, August 2017)